RWLK REWALK ROBOTICS LTD

ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020, before the U.S. financial markets open.

Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:

Time8:30 A.M EST
Toll free (U.S.)(844) 423-9889
International (U.S)(716) 247-5804
Germany08 00 18 15 287
Israel18 09 31 53 62
Access Code9366548
Webcast (live and replay) 

under the ‘Investors’ section'.

The archived webcast will be available via the following or through the 'Investors' section' on . 

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit .

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. 

Investor Contact:

Ori Gon

Chief Financial Officer 

ReWalk Robotics Ltd.

T:  

E: 

EN
07/08/2020

Underlying

RWLKREWALK ROBOTICS LTD

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on REWALK ROBOTICS LTD

 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Successfully Closes on Strategic Partnership with Oramed

Lifeward Successfully Closes on Strategic Partnership with Oramed HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that it has closed on the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). The transaction has positioned Lifeward as a diversified biomedical innovation company with an expected clear...

March 25, 2026 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology Lower operating expenses and cash usage reflect improved operational efficiency HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 18, 2026 (GLOBE NEWSWIRE) -- Lifeward Lt...

March 18, 2026 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Receives Shareholder Approval to Close on Strategic Partnersh...

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform’s clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovati...

March 13, 2026 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced it has received a notification letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) ("Rule"). To regain compliance with the...

March 11, 2026 1 EN
 PRESS RELEASE
Free
RWLK REWALK ROBOTICS...

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results...

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and full year 2025 financial results before the markets open on Wednesday, March 18, 2026. Mark Grant, President and Chief Executive Officer, and Almog Adar, Chief Financial ...

March 10, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch